Pharmaceutical Sales Certification (PSC) Pharmacy Sales
Rep Certificate Exam – 135+ Verified Questions & Answers
(2026/2027) Instant Pdf Download
This comprehensive guide contains 135+ verified questions and answers for
the Pharmaceutical Sales Certification (PSC) Exam based on the 2026/2027 curriculum.
All correct answers are in bold italic with italic rationales .
SECTION 1: INDUSTRY OVERVIEW & ECONOMICS (Questions 1-20)
Q1. Which of the following statements most accurately reflects the social and
economic importance of the pharmaceutical industry in the United States?
A. It is a low-risk, moderate-return industry
B. It accounts for less than 10% of total U.S. healthcare spending while
delivering disproportionate clinical value
C. Prescription drugs are the primary driver of rising healthcare costs
D. The U.S. represents only 15–20% of global pharmaceutical revenues
* Prescription and non-prescription drugs represent approximately 8–10% of total U.S.
healthcare expenditures yet are responsible for dramatic reductions in hospitalization,
surgery, and long-term care costs. The U.S. accounts for ~45–50% of global
pharmaceutical revenues .*
Q2. In 2024–2025, which geographic region continues to represent the largest single
market for ethical pharmaceuticals?
A. European Union (27 countries combined)
B. Japan
C. United States
D. China
The U.S. still captures approximately 48–50% of global pharmaceutical sales due to higher
pricing, faster adoption of new therapies, and a large insured population .
,Q3. A pharmaceutical sales representative is explaining to a physician why R&D
costs are so high. Which of the following is the most accurate statistic to quote?
A. For every 5,000–10,000 compounds screened, only 1 receives FDA approval
B. Average fully capitalized cost to bring a new molecular entity to market now
exceeds $2.6 billion
C. Phase III trials rarely fail
D. Generic drugs fund most new R&D
* Tufts Center for the Study of Drug Development estimates out-of-pocket and capitalized
cost at $2.6–$2.9 billion per approved new drug, with only ~1 in 5,000–10,000 screened
compounds reaching approval .*
Q4. Which of the following is the single most important driver of pharmaceutical
industry revenue growth from 2015 to 2025?
A. Population growth in emerging markets
B. Increased life expectancy and the aging population in developed countries
C. Rising generic penetration
D. Expansion of over-the-counter switching
* The aging baby-boomer population (65+ age group growing from 46 million in 2015 to over
80 million in 2025) drives demand for chronic therapies in oncology, cardiology, neurology,
rheumatology, and diabetes .*
Q5. Pharmaceutical spending as a percentage of total U.S. healthcare expenditures in
2024–2025 is approximately:
A. 5–7%
B. 8–10%
C. 15–20%
D. 25–30%
Prescription drug spending remains approximately 8–10% of total healthcare expenditures,
contrary to public perception that drugs are the primary cost driver .
Q6. What is the approximate global market revenue of the pharmaceutical industry?
, A. $500 billion
B. $950 billion
C. $1.5 trillion
D. $2 trillion
The global pharmaceutical industry generates approximately $950 billion in annual
revenue, with the U.S., Western Europe, and Japan representing the largest markets .
Q7. Which country accounts for roughly half of the world's pharmaceutical revenues?
A. China
B. Germany
C. United States
D. Japan
The United States accounts for approximately 50% (half) of all global pharmaceutical
revenues .
Q8. What factors have significantly contributed to recent growth in the
pharmaceutical industry?
A. Declining birth rates
B. Population growth and increasing life expectancy
C. Decreased chronic disease prevalence
D. Lower drug prices
Population growth and increased life expectancy drive pharmaceutical industry growth by
expanding the elderly population, which consumes more medications .
Q9. Why is prescription drug therapy considered cost-effective?
A. It has no side effects
B. It eliminates the need for costly surgeries and hospitalizations
C. It is always covered by insurance
D. It requires no physician oversight
, Prescription drug therapy often eliminates the need for costly interventions like surgery,
nursing care, and hospitalization, making it cost-effective for insurance companies and
healthcare providers .
Q10. How has the aging population influenced pharmaceutical sales?
A. Decreased opportunities for growth
B. Increased opportunities for growth in the industry
C. Had no effect
D. Shifted focus to pediatric medicines
Senior citizens consume over three times as many medications as people under age 65,
creating significant growth opportunities for the pharmaceutical industry .
Q11. What is the job description of a Pharmaceutical Sales Representative?
A. Sell products at the lowest possible price
B. Provide valid, proven, R&D-based information about the company's
medications so physicians can apply it in their medical practices
C. Process insurance claims
D. Manufacture pharmaceutical products
Pharmaceutical sales reps provide evidence-based, research-derived information to
physicians, enabling informed prescribing decisions .
Q12. Which of the following has fueled recent growth in the pharmaceutical industry?
A. Population growth and increased life expectancies
B. Decreased healthcare spending
C. Lower prescription drug use
D. Reduced chronic disease rates
Both population growth and increased life expectancy increase the number of elderly
persons who become candidates for drug therapies .
Q13. According to the manual, which statement accurately describes the predicted
relationship between pharmaceutical companies and genomic research facilities?
A. Partnerships will be immediately profitable
Rep Certificate Exam – 135+ Verified Questions & Answers
(2026/2027) Instant Pdf Download
This comprehensive guide contains 135+ verified questions and answers for
the Pharmaceutical Sales Certification (PSC) Exam based on the 2026/2027 curriculum.
All correct answers are in bold italic with italic rationales .
SECTION 1: INDUSTRY OVERVIEW & ECONOMICS (Questions 1-20)
Q1. Which of the following statements most accurately reflects the social and
economic importance of the pharmaceutical industry in the United States?
A. It is a low-risk, moderate-return industry
B. It accounts for less than 10% of total U.S. healthcare spending while
delivering disproportionate clinical value
C. Prescription drugs are the primary driver of rising healthcare costs
D. The U.S. represents only 15–20% of global pharmaceutical revenues
* Prescription and non-prescription drugs represent approximately 8–10% of total U.S.
healthcare expenditures yet are responsible for dramatic reductions in hospitalization,
surgery, and long-term care costs. The U.S. accounts for ~45–50% of global
pharmaceutical revenues .*
Q2. In 2024–2025, which geographic region continues to represent the largest single
market for ethical pharmaceuticals?
A. European Union (27 countries combined)
B. Japan
C. United States
D. China
The U.S. still captures approximately 48–50% of global pharmaceutical sales due to higher
pricing, faster adoption of new therapies, and a large insured population .
,Q3. A pharmaceutical sales representative is explaining to a physician why R&D
costs are so high. Which of the following is the most accurate statistic to quote?
A. For every 5,000–10,000 compounds screened, only 1 receives FDA approval
B. Average fully capitalized cost to bring a new molecular entity to market now
exceeds $2.6 billion
C. Phase III trials rarely fail
D. Generic drugs fund most new R&D
* Tufts Center for the Study of Drug Development estimates out-of-pocket and capitalized
cost at $2.6–$2.9 billion per approved new drug, with only ~1 in 5,000–10,000 screened
compounds reaching approval .*
Q4. Which of the following is the single most important driver of pharmaceutical
industry revenue growth from 2015 to 2025?
A. Population growth in emerging markets
B. Increased life expectancy and the aging population in developed countries
C. Rising generic penetration
D. Expansion of over-the-counter switching
* The aging baby-boomer population (65+ age group growing from 46 million in 2015 to over
80 million in 2025) drives demand for chronic therapies in oncology, cardiology, neurology,
rheumatology, and diabetes .*
Q5. Pharmaceutical spending as a percentage of total U.S. healthcare expenditures in
2024–2025 is approximately:
A. 5–7%
B. 8–10%
C. 15–20%
D. 25–30%
Prescription drug spending remains approximately 8–10% of total healthcare expenditures,
contrary to public perception that drugs are the primary cost driver .
Q6. What is the approximate global market revenue of the pharmaceutical industry?
, A. $500 billion
B. $950 billion
C. $1.5 trillion
D. $2 trillion
The global pharmaceutical industry generates approximately $950 billion in annual
revenue, with the U.S., Western Europe, and Japan representing the largest markets .
Q7. Which country accounts for roughly half of the world's pharmaceutical revenues?
A. China
B. Germany
C. United States
D. Japan
The United States accounts for approximately 50% (half) of all global pharmaceutical
revenues .
Q8. What factors have significantly contributed to recent growth in the
pharmaceutical industry?
A. Declining birth rates
B. Population growth and increasing life expectancy
C. Decreased chronic disease prevalence
D. Lower drug prices
Population growth and increased life expectancy drive pharmaceutical industry growth by
expanding the elderly population, which consumes more medications .
Q9. Why is prescription drug therapy considered cost-effective?
A. It has no side effects
B. It eliminates the need for costly surgeries and hospitalizations
C. It is always covered by insurance
D. It requires no physician oversight
, Prescription drug therapy often eliminates the need for costly interventions like surgery,
nursing care, and hospitalization, making it cost-effective for insurance companies and
healthcare providers .
Q10. How has the aging population influenced pharmaceutical sales?
A. Decreased opportunities for growth
B. Increased opportunities for growth in the industry
C. Had no effect
D. Shifted focus to pediatric medicines
Senior citizens consume over three times as many medications as people under age 65,
creating significant growth opportunities for the pharmaceutical industry .
Q11. What is the job description of a Pharmaceutical Sales Representative?
A. Sell products at the lowest possible price
B. Provide valid, proven, R&D-based information about the company's
medications so physicians can apply it in their medical practices
C. Process insurance claims
D. Manufacture pharmaceutical products
Pharmaceutical sales reps provide evidence-based, research-derived information to
physicians, enabling informed prescribing decisions .
Q12. Which of the following has fueled recent growth in the pharmaceutical industry?
A. Population growth and increased life expectancies
B. Decreased healthcare spending
C. Lower prescription drug use
D. Reduced chronic disease rates
Both population growth and increased life expectancy increase the number of elderly
persons who become candidates for drug therapies .
Q13. According to the manual, which statement accurately describes the predicted
relationship between pharmaceutical companies and genomic research facilities?
A. Partnerships will be immediately profitable
